N

Nightingale Health Oyj
OMXH:HEALTH

Watchlist Manager
Nightingale Health Oyj
OMXH:HEALTH
Watchlist
Price: 2.76 EUR -2.13% Market Closed
Market Cap: 166.5m EUR
Have any thoughts about
Nightingale Health Oyj?
Write Note

Intrinsic Value

HEALTH's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one HEALTH stock under the Base Case scenario is 0.98 EUR. Compared to the current market price of 2.76 EUR, Nightingale Health Oyj is Overvalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HEALTH Intrinsic Value
0.98 EUR
Overvaluation 65%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation Backtest
Nightingale Health Oyj

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HEALTH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HEALTH?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Nightingale Health Oyj

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Nightingale Health Oyj

Provide an overview of the primary business activities
of Nightingale Health Oyj.

What unique competitive advantages
does Nightingale Health Oyj hold over its rivals?

What risks and challenges
does Nightingale Health Oyj face in the near future?

Summarize the latest earnings call
of Nightingale Health Oyj.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nightingale Health Oyj.

Provide P/S
for Nightingale Health Oyj.

Provide P/E
for Nightingale Health Oyj.

Provide P/OCF
for Nightingale Health Oyj.

Provide P/FCFE
for Nightingale Health Oyj.

Provide P/B
for Nightingale Health Oyj.

Provide EV/S
for Nightingale Health Oyj.

Provide EV/GP
for Nightingale Health Oyj.

Provide EV/EBITDA
for Nightingale Health Oyj.

Provide EV/EBIT
for Nightingale Health Oyj.

Provide EV/OCF
for Nightingale Health Oyj.

Provide EV/FCFF
for Nightingale Health Oyj.

Provide EV/IC
for Nightingale Health Oyj.

Show me price targets
for Nightingale Health Oyj made by professional analysts.

What are the Revenue projections
for Nightingale Health Oyj?

How accurate were the past Revenue estimates
for Nightingale Health Oyj?

What are the Net Income projections
for Nightingale Health Oyj?

How accurate were the past Net Income estimates
for Nightingale Health Oyj?

What are the EPS projections
for Nightingale Health Oyj?

How accurate were the past EPS estimates
for Nightingale Health Oyj?

What are the EBIT projections
for Nightingale Health Oyj?

How accurate were the past EBIT estimates
for Nightingale Health Oyj?

Compare the revenue forecasts
for Nightingale Health Oyj with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nightingale Health Oyj and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nightingale Health Oyj against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nightingale Health Oyj compared to its peers.

Compare the P/E ratios
of Nightingale Health Oyj against its peers.

Discuss the investment returns and shareholder value creation
comparing Nightingale Health Oyj with its peers.

Analyze the financial leverage
of Nightingale Health Oyj compared to its main competitors.

Show all profitability ratios
for Nightingale Health Oyj.

Provide ROE
for Nightingale Health Oyj.

Provide ROA
for Nightingale Health Oyj.

Provide ROIC
for Nightingale Health Oyj.

Provide ROCE
for Nightingale Health Oyj.

Provide Gross Margin
for Nightingale Health Oyj.

Provide Operating Margin
for Nightingale Health Oyj.

Provide Net Margin
for Nightingale Health Oyj.

Provide FCF Margin
for Nightingale Health Oyj.

Show all solvency ratios
for Nightingale Health Oyj.

Provide D/E Ratio
for Nightingale Health Oyj.

Provide D/A Ratio
for Nightingale Health Oyj.

Provide Interest Coverage Ratio
for Nightingale Health Oyj.

Provide Altman Z-Score Ratio
for Nightingale Health Oyj.

Provide Quick Ratio
for Nightingale Health Oyj.

Provide Current Ratio
for Nightingale Health Oyj.

Provide Cash Ratio
for Nightingale Health Oyj.

What is the historical Revenue growth
over the last 5 years for Nightingale Health Oyj?

What is the historical Net Income growth
over the last 5 years for Nightingale Health Oyj?

What is the current Free Cash Flow
of Nightingale Health Oyj?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nightingale Health Oyj.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Nightingale Health Oyj

Balance Sheet Decomposition
Nightingale Health Oyj

Current Assets 68.4m
Cash & Short-Term Investments 66m
Receivables 1.7m
Other Current Assets 704k
Non-Current Assets 22.4m
Long-Term Investments 37k
PP&E 8.6m
Intangibles 13.3m
Other Non-Current Assets 439k
Current Liabilities 7m
Accounts Payable 4.3m
Other Current Liabilities 2.7m
Non-Current Liabilities 1m
Long-Term Debt 985k
Other Non-Current Liabilities 23k
Efficiency

Earnings Waterfall
Nightingale Health Oyj

Revenue
4.4m EUR
Cost of Revenue
-1.5m EUR
Gross Profit
2.9m EUR
Operating Expenses
-21.5m EUR
Operating Income
-18.6m EUR
Other Expenses
1.1m EUR
Net Income
-17.5m EUR

Free Cash Flow Analysis
Nightingale Health Oyj

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Nightingale Health continues to display steady financial improvements and strategic growth. The company reported a 4% year-over-year increase in full-year revenue to EUR 4.358 million, marking its highest revenue to date. Despite a net loss of EUR 17.46 million, Nightingale maintains robust financial health with EUR 63 million in net cash and no debt on its balance sheet. The company emphasizes a shift towards more stable healthcare revenue, boosted by new deals such as the Terveystalo Occupational Health agreement. With multiple international deals in progress, Nightingale forecasts becoming EBITDA positive in the midterm and aims for significant international expansion.

What is Earnings Call?
Fundamental Scores

HEALTH Profitability Score
Profitability Due Diligence

Nightingale Health Oyj's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
Positive 1-Year Revenue Growth
28/100
Profitability
Score

Nightingale Health Oyj's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

HEALTH Solvency Score
Solvency Due Diligence

Nightingale Health Oyj's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Nightingale Health Oyj's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HEALTH Price Targets Summary
Nightingale Health Oyj

Wall Street analysts forecast HEALTH stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HEALTH is 1.99 EUR with a low forecast of 1.01 EUR and a high forecast of 3.05 EUR.

Lowest
Price Target
1.01 EUR
63% Downside
Average
Price Target
1.99 EUR
28% Downside
Highest
Price Target
3.05 EUR
10% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HEALTH?

Click here to dive deeper.

Dividends

Nightingale Health Oyj
does not pay dividends
Shareholder Yield

Current shareholder yield for HEALTH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Nightingale Health Oyj

Country

Finland

Industry

Health Care

Market Cap

166.5m EUR

Dividend Yield

0%

Description

Nightingale Health Oyj engages in the development of health data platform for healthcare service providers. The company is headquartered in Helsinki, Etela-Suomen and currently employs 77 full-time employees. The company went IPO on 2021-03-19. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The firm provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Group comprises the parent Company’s subsidiaries: Nightingale Health United States Inc, Nightingale Health Asia Pte Ltd, Nightingale Health Japan KK as well as NG Health Sweden AB. The firm owns and independently oversees two laboratories in Finland, in Helsinki and Kuopio, and one laboratory in Tokyo, Japan.

Contact

ETELA-SUOMEN
Helsinki
Mannerheimintie 164a
nightingalehealth.com

IPO

2021-03-19

Employees

77

Officers

Founder, CEO & Director
Mr. Teemu Suna
Founder, CTO & Director
Mr. Antti Kangas
Co-Founder & COO
Ms. Satu Saksman
Founder & Scientific Director
Mr. Peter Wurtz Ph.D.
Founder & Laboratory Director
Mr. Pasi Soininen Ph.D.
Chief Financial Officer
Mr. Tuukka Paavola
Show More
Chief Scientific Officer
Mr. Jeffrey Barrett Ph.D.
Chief Legal Officer
Ms. Minja Salmio
Chief Research & Development Officer
Ms. Salla Ruosaari Ph.D.
Director of Business Operations
Ms. Laura Pulkkinen
Show Less

See Also

Discover More
What is the Intrinsic Value of one HEALTH stock?

The intrinsic value of one HEALTH stock under the Base Case scenario is 0.98 EUR.

Is HEALTH stock undervalued or overvalued?

Compared to the current market price of 2.76 EUR, Nightingale Health Oyj is Overvalued by 65%.

Back to Top